Results 241 to 250 of about 421,693 (309)

Preliminary evidence of improved liver biomarkers in adolescents with obesity and suspected metabolic dysfunction‐associated steatotic liver disease treated with semaglutide: A case series

open access: yesJPGN Reports, EarlyView.
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) affects 30%–40% of youth with obesity and lacks approved pharmacologic therapies. In this single‐center retrospective case series at a tertiary care safety‐net children's hospital, we evaluated five adolescents (mean age: 17.0 years; 100% Hispanic; 60% male; mean body mass index:
Rachel Schenker   +3 more
wiley   +1 more source

Lorazepam and Survival in Asian Patients with Pancreatic Cancer: A Retrospective Cohort Study. [PDF]

open access: yesJ Gastrointest Cancer
Lee TS   +6 more
europepmc   +1 more source

Personalized AZithromycin/metronidAZole + dietary therapy in pediatric Crohn disease: Results of a pilot study

open access: yes
Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Charlotte M. Verburgt   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy